Cargando…
Development of Lipidoid Nanoparticles for siRNA Delivery to Neural Cells
Lipidoid nanoparticles (LNPs) are the delivery platform in Onpattro, the first FDA-approved siRNA drug. LNPs are also the carriers in the Pfizer-BioNTech and Moderna COVID-19 mRNA vaccines. While these applications have demonstrated that LNPs effectively deliver nucleic acids to hepatic and muscle c...
Autores principales: | Khare, Purva, Dave, Kandarp M., Kamte, Yashika S., Manoharan, Muthiah A., O’Donnell, Lauren A., Manickam, Devika S. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Springer International Publishing
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8648339/ https://www.ncbi.nlm.nih.gov/pubmed/34873640 http://dx.doi.org/10.1208/s12248-021-00653-2 |
Ejemplares similares
-
Lipidoid Nanoparticles for siRNA Delivery to the Intestinal Epithelium: In Vitro Investigations in a Caco-2 Model
por: Ball, Rebecca L., et al.
Publicado: (2015) -
Optimizing the Intracellular Delivery of Therapeutic Anti-inflammatory TNF-α siRNA to Activated Macrophages Using Lipidoid-Polymer Hybrid Nanoparticles
por: Lokras, Abhijeet, et al.
Publicado: (2021) -
Neurotransmitter-derived lipidoids (NT-lipidoids) for enhanced brain delivery through intravenous injection
por: Ma, Feihe, et al.
Publicado: (2020) -
Neural Stem Cells: What Happens When They Go Viral?
por: Kamte, Yashika S., et al.
Publicado: (2021) -
Immunogenicity Testing of Lipidoids In Vitro and In Silico: Modulating Lipidoid-Mediated TLR4 Activation by Nanoparticle Design
por: de Groot, Anne Marit, et al.
Publicado: (2018)